Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

PharmaCielo Ltd. (PCLOF)

Compare
0.0490
+0.0001
+(0.31%)
As of April 10 at 4:00:00 PM EDT. Market Open.
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,479.7970
3,479.7970
1,541.7490
5,308.5170
1,944.9980
Cost of Revenue
2,748.9190
2,748.9190
2,910.5860
4,627.2290
6,253.3630
Gross Profit
730.8780
730.8780
-1,368.8370
681.2880
-4,308.3650
Operating Expense
5,632.9560
5,632.9560
8,673.7590
12,115.6650
20,885.4330
Operating Income
-4,902.0780
-4,902.0780
-10,042.5960
-11,434.3770
-25,193.7980
Net Non Operating Interest Income Expense
-3,443.8130
-3,443.8130
-2,864.3850
-1,592.8760
-558.9200
Other Income Expense
-795.5850
-795.5850
-3,390.6540
-1,489.0980
-876.9750
Pretax Income
-9,141.4760
-9,141.4760
-16,297.6350
-14,516.3510
-26,629.6930
Net Income Common Stockholders
-9,141.4760
-9,141.4760
-16,297.6350
-14,516.3510
-26,629.6930
Diluted NI Available to Com Stockholders
-9,141.4760
-9,141.4760
-16,297.6350
-14,516.3510
-26,629.6930
Basic EPS
-0.05
--
-0.10
-0.10
-0.18
Diluted EPS
-0.05
--
-0.10
-0.10
-0.18
Basic Average Shares
171,022.2740
--
160,080.9010
150,977.1190
145,638.2540
Diluted Average Shares
171,022.2740
--
160,080.9010
150,977.1190
145,638.2540
Total Expenses
8,381.8750
8,381.8750
11,584.3450
16,742.8940
27,138.7960
Net Income from Continuing & Discontinued Operation
-9,141.4760
-9,141.4760
-16,297.6350
-14,516.3510
-26,629.6930
Normalized Income
-8,274.0520
-8,274.0520
-12,570.7540
-13,035.1900
-26,088.1260
Interest Income
0.0100
0.0100
0.1760
1.8280
2.3740
Interest Expense
3,273.5550
3,273.5550
2,694.2020
1,535.8510
471.5590
Net Interest Income
-3,443.8130
-3,443.8130
-2,864.3850
-1,592.8760
-558.9200
EBIT
-5,867.9210
-5,867.9210
-13,603.4330
-12,980.5000
-26,158.1340
EBITDA
-4,602.7520
-4,602.7520
-12,188.9830
-11,401.1790
-24,839.5390
Reconciled Cost of Revenue
1,696.6920
1,696.6920
1,837.7920
3,500.6470
6,315.4740
Reconciled Depreciation
1,265.1690
1,265.1690
1,414.4500
1,579.3210
1,256.4840
Net Income from Continuing Operation Net Minority Interest
-9,141.4760
-9,141.4760
-16,297.6350
-14,516.3510
-26,629.6930
Total Unusual Items Excluding Goodwill
-867.4240
-867.4240
-3,726.8810
-1,481.1610
-541.5670
Total Unusual Items
-867.4240
-867.4240
-3,726.8810
-1,481.1610
-541.5670
Normalized EBITDA
-3,735.3280
-3,735.3280
-8,462.1020
-9,920.0180
-24,297.9720
12/31/2021 - 1/25/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CANQF CanaQuest Medical Corp.
0.0188
0.00%
 
NOBDF North Bud Farms Inc.
0.0000
0.00%
 
CNADF CanadaBis Capital Inc.
0.0625
0.00%
 
XTXXF Adastra Holdings Ltd.
0.0378
0.00%
 
RAMM.CN RAMM Pharma Corp.
0.0150
0.00%
 
TLRY.VI Tilray Brands, Inc.
0.4220
-4.09%
 
VIBEF Vibe Growth Corporation
0.0500
+27.88%
 
HYEX Healthy Extracts Inc.
3.2400
0.00%
 
ETRGF Entourage Health Corp.
0.0040
+14.29%
 
FLWPF THE FLOWR CORPORATION
0.0190
0.00%